“…In this issue of the Journal, Tolomeo et al 5 . conduct a post‐hoc analysis using combined individual patient data from five large multinational, randomized, double‐blind chronic HF trials, covering both reduced (HFrEF) and preserved (HFpEF) ejection fraction (HFrEF: PARADIGM‐HF, DAPA‐HF, and ATMOSPHERE, HFpEF: PARAGON‐HF, and I‐PRESERVE).…”